will blue cross blue shield cover semaglutide of Michigan won't popular weight-loss drugs Weight loss medication covered by

With that established, here is what the paper reports

Whilst the market is currently led by Novo Nordisks semaglutide (Ozempic/Wegovy) and Eli Lillys tirzepatide (Mounjaro/Zepbound), stronger competition is expected with new entrants (Boehringer Ingelheim, Amgen, Pfizer, Roche amongst others) offering novel mechanisms (dual agonists, triple agonists and amylins), formulations (oral vs injectable) and dosing regimens (daily vs weekly vs monthly).

This comprehensive approach enhances patient safety, improves treatment outcomes, and fosters a collaborative patient-provider relationship

From a medical standpoint, that is not the issue

20057955#:~:text=Weight%20loss%20can%20vary%20de pending,or%20kg)%20when%20using%20liraglutide.